Back to search results

Home Rehabilitation After Stroke for Underserved Texas Communities

This study is looking at two ways to help people recover after a stroke. One group will receive standard post-acute stroke care (PASUC), which includes physical, occupational, and speech therapy, plus medical care. The other group will receive PASUC along with a program called VAST (Virtually Assisted Home Rehabilitation After Acute STroke). VAST is a 4-week home-based program that uses telerehabilitation (rehabilitation services delivered remotely) and health coaching. The study wants to see if VAST helps people improve their ability to do daily activities and move around better. You may be able to join if you are 18 or older, recently had an ischemic stroke or intracerebral hemorrhage, and need rehabilitation. The study is currently unclear about its recruitment status.

Study design
This interventional study plans to enroll 80 participants to compare two different rehabilitation approaches after a stroke.
What's involved
Participants will receive either standard post-acute stroke care or standard care plus a 4-week home-based telerehabilitation program. Your progress will be checked at the start, 6 weeks, and 18 weeks.
Compensation
Not stated in the trial record.
Follow-up
Participants will be followed for 18 weeks after the start of the study to assess changes in their abilities.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT07597226

Virtually Assisted Home Rehabilitation After Stroke for Underserved Texas Communities

Not Yet Recruiting
NAAges 18+InterventionalTreatment
The University of Texas Health Science Center, Houston
~80 participants
Updated 2026-05-19 on ClinicalTrials.gov
What's tested:VASTPASUC alone

At a glance

Recruiting sites
0 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Change in perceived ability to perform activities of daily living and functional mobility as assessed by the Stroke Impact Scale (SIS)-Activity subscale
Measured over Baseline, 6 weeks, 18 weeks

Conditions

Stroke

Explore related trials

Acute Ischemic StrokeCerebral Hemorrhage

Where it's being run

1 sites across 1 states
Texas1

Study leadership

  • Sean Savitz, MD · PRINCIPAL_INVESTIGATOR · The University of Texas Health Science Center, Houston

Who to contact

Sean Savitz, MD
[email protected]
(713) 500-7083
Email the study team

Opens a ready-to-send draft in your own email app — review before sending.

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

Hospital admission with primary ICD-10 discharge diagnosis of Acute Ischemic Stroke (AIS) or Intracerebral Hemorrhage (ICH)
Post-stroke functional deficits warranting PASUC rehabilitation
Clinically stable and appropriate for discharge per acute care facility
Completion of a rehabilitation evaluation within the acute setting
Planned discharge to home (with or without Home Health (HH)/Outpatient Rehabilitation (OPR), Inpatient Rehabilitation Facility (IRF), or Skilled Nursing Facility (SNF)
Ability to speak and read English or Spanish
Ability to provide informed consent (patient or LAR)
Access to a video-capable device and internet

Exclusion

Clinically unstable medical condition
Poorly controlled severe mental illness
Planned discharge to a long-term care facility (LTACH)
Inability to complete follow-up (psychiatric hospitalization, hospice, incarceration, homelessness)
Discharge against medical advice
Significant language impairment (NIHSS Commands \>1 or Best Language \>2)- Cognitive impairment (Six-Item, PROMIS) -Severe depression (PHQ-8 \>20 or psychiatric hospitalization previous 30 days)- Pre-stroke mRS \>3
Other neurological or musculoskeletal conditions substantially limiting participation o Patients excluded for one of these criteria may be reassessed at 60-days to see if improvement has occurred.

What this trial measures

  • Change in perceived ability to perform activities of daily living and functional mobility as assessed by the Stroke Impact Scale (SIS)-Activity subscaleBaseline, 6 weeks, 18 weeks

    This is scored from ange 0-100, with higher scores indicating better function